Folia Parasitologica 50[1] 19-22 (2003) | DOI: 10.14411/fp.2003.003
Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model
- 1 Laboratoire de Parasitologie, Faculté de Médecine-Pharmacie, and ADEN, UPRES-EA 3234, 76138 Rouen, France
- 2 Laboratoire d'Immunologie et Immunopathologie, CHU Clemenceau, 14033 Caen Cedex, France
- 3 Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK
Cryptosporidium parvum, Tyzzer, 1912 is identified as a common cause of diarrhoea in immunocompetent individuals. In immunocompromised, especially HIV-infected subjects, cryptosporidiosis causes severe chronic diarrhoea. In this study, nitazoxanide (NTZ) was compared for curative activity with sinefungin (SNF) and paromomycin (PRM) in immunosuppressed rats, a screening model for anticryptosporidial agents. NTZ at either 50 mg/kg/day, 100 mg/kg/day or 200 mg/kg/day resulted in seven days in a dose-dependent inhibition of oocyst shedding similar to that obtained with SNF (10 mg/kg/day) and PRM (100 mg/kg/day). Further discontinuation of SNF or PRM 100 mg/kg/day therapy resulted in early relapse of oocyst shedding which reached the pre-treatment levels in 2-4 days. In contrast, seven days after discontinuation of therapy, shedding inhibition was unchanged in NTZ-treated rats. Data prompt further assessment of the activity of NTZ on sequestered C. parvum.
Keywords: Cryptosporidium parvum, nitazoxanide, immunosuppressed rat model
Received: June 10, 2002; Accepted: October 2, 2002; Published: March 1, 2003 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- BICART-SEE A., MASSIP P., LINAS M.D., DATRY A. 2000: Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS. Antimicrob. Agents Chemother. 44: 167-168
Go to original source...
Go to PubMed... - BLAGBURN B.L., DRAIN K.L., LAND T.M., KINARD R.G., MOORE P.H., LINDSAY D.S., PATRICK D.A., BOYKIN D.W., TIDWELL R.R. 1998: Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob. Agents Chemother. 42: 2877-2882
Go to original source...
Go to PubMed... - BLAGBURN B.L., SOAVE R. 1997: Prophylaxis and chemotherapy: human and animal. In: R. Fayer (Ed.), Cryptosporidium and Cryptosporidiosis. CRC Press, Boca Raton, pp. 111-128
- BRASSEUR P., FAVENNEC L., LEMETEIL D., ROUSSEL F., BALLET J.J. 1994: An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin. Folia Parasitol. 41: 13-16
Go to PubMed... - BRASSEUR P., LEMETEIL D., BALLET J.J. 1988: Rat model for human cryptosporidiosis. J. Clin. Microbiol. 26: 1037-1039
Go to original source...
Go to PubMed... - DAVIS L.J., SOAVE R., DUDLEY R.E., FESSEL J.W., FAULKNER S., MAMAKOS J.P. 2000: Nitazoxanide (NTZ) for AIDS-related cryptosporidial diarrhea (CD): an open-label safety, efficacy and pharmacokinetic study. In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C., abstract LM50, p. 289
- DOUMBO O., ROSSIGNOL J.F., PICHARD E., TRAORE H.A., DEMBELE T.M., DIAKITE M., TRAORE F., DIALLO D.A. 1997: Nitazoxanide in treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am. J. Trop. Med. Hyg. 56: 637-639
Go to original source...
Go to PubMed... - DUBREUIL L., HOUCKE I., MOUTON Y., ROSSIGNOL J.F. 1996: In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob. Agents Chemother. 40: 2260-2270
Go to original source... - GRIFFITHS J.L. 1998: Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment and diagnosis. Adv. Parasitol. 40: 37-85
Go to original source...
Go to PubMed... - HEALEY M.C., YANG S., RASMUSSEN K.R., JACKSON M.K., DU C. 1995: Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. J. Parasitol. 81: 114-116
Go to original source...
Go to PubMed... - HEINE J. 1982: Eine einfache Nachweismethode fuer Kryptosporidien im Kot. Zentralbl. Veterinaermed. 29: 324-327
Go to original source... - LEMETEIL D., ROUSSEL F., FAVENNEC L., BALLET J.J., BRASSEUR P. 1993: Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. J. Infect. Dis. 167: 766-768
Go to original source...
Go to PubMed... - McVAY C.S., ROLFE R.D. 2000: In vitro and in vivo activities of nitazoxanide against Clostridium difficile. Antimicrob. Agents Chemother. 44: 2254-2258
Go to original source...
Go to PubMed... - MEGRAUD F., OCCHIALINI A., ROSSIGNOL J.F. 1998: Nitazoxanide, a potential drug to eradicate Helicobacter pylori with no cross resistance to metronidazole. Antimicrob. Agents Chemother. 42: 2836-2840
Go to original source...
Go to PubMed... - ROSSIGNOL J.F., AYOUB A., AYERS M.S. 2001: Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J. Infect. Dis. 184: 103-106
Go to original source...
Go to PubMed... - ROSSIGNOL J.F., ABAZA H., FRIEDMAN H. 1998a: Successful treatment of human fascioliasis with nitazoxanide. Trans. R. Soc. Trop. Med. Hyg. 92: 103-104
Go to original source...
Go to PubMed... - ROSSIGNOL J.F., HIDALGO H., FEREGRINO M., HIGUERA F., GOMEZ W.H., ROMERO J.L., PADIERNA J., GEYNE A., AYERS M.S. 1998b: A double-blind placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans. R. Soc. Trop. Med. Hyg. 92: 663-666
Go to original source...
Go to PubMed... - ROSSIGNOL J.F., MAISONNEUVE H. 1984: Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana. Am. J. Trop. Med. Hyg. 33: 511-512
Go to original source...
Go to PubMed... - ROUSSEL F., FAVENNEC L., LEMETEIL D., TAYOT J., BALLET J.J., BRASSEUR P. 1996: Biliary tract cryptosporidiosis in an immunosuppressed rat model. Int. J. Parasitol. 26: 19-24
Go to original source...
Go to PubMed... - THEODOS C.M., GRIFFITHS J.K., D'ONFRO J., FAIRFIELD A., TZIPORI S. 1998: Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob. Agents Chemother. 42: 1959-1965
Go to original source...
Go to PubMed... - TZIPORI S. 1998: Cryptosporidiosis: laboratory investigation and chemotherapy. Adv. Parasitol. 40: 187-221
Go to original source...
Go to PubMed... - TZIPORI S., RAND W., GRIFFITHS J., WIDMER G., CRABB J. 1994: Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin. Diagn. Lab. Immunol. 1: 450-463
Go to original source...
Go to PubMed... - VERDON R., POLIANSKI J., GAUDEBOUT C., MARCHE C., GARRY L., CARBON C., POCIDALO J.J. 1995: Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat model. Antimicrob. Agents Chemother. 39: 2155-2157
Go to original source...
Go to PubMed...


